Open tender · Germany · Pharmaceutical products
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Trastuzumab (ausschließlich 600mg i.e.D.), ATC L01FD01 für die Zeit 01.06.2026 - 31.05.2028
In EnglishConclusion of a non-exclusive discount agreement under § 130a para. 8 SGB V for the active ingredient Trastuzumab (exclusively 600mg i.e.D.), ATC L01FD01 for the period 01.06.2026 - 31.05.2028
DAK-Gesundheit in Germany is inviting bids for “Conclusion of a non-exclusive discount agreement under § 130a para. 8 SGB V for the active ingredient Trastuzumab (exclusively 600mg i.e.D.), ATC…”. Bids close on 5 April 2028, 12:00 CEST. askTender lists every requirement to qualify and checks whether your company meets them.
The work
Framework discount agreement for Trastuzumab 600mg i.e.D., ATC L01FD01, for the period 01.06.2026 to 31.05.2028.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
askTender has broken this tender down into 0 requirements to qualify and the 5 documents a bidder must file.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences